The largest database of trusted experimental protocols

6 protocols using anti mouse cd16 32 fc blocker

1

Multiparameter Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were collected and washed with FACS buffer twice, followed by incubation with anti-mouse CD16/32 (Fc blocker, #553141, BD Biosciences) for 5 min at 4 °C. Then, cells were stained with anti-mouse CD3e (APC, #553066, BD Biosciences), CD4 (PE, #553652, BD Biosciences), CD8 (BV605, #100744, BioLegend), CD69 (PECY7, #104511, BioLegend), CTLA4 (PE, #553720, BD Biosciences), PD-1 (FITC, #135213, BioLegend), CD8 (FITC, #100705, BioLegend), CD4 (APCCY7, # 100413, BioLegend), or CD8 (PECY7, #100721, BioLegend) for 30 min at 4 °C. Each sample was washed with FACS buffer twice and resuspended in 0.5 ml FACS buffer. DAPI was used to exclude dead cells. Fluorescent cells were detected with CytoFLEX LX Flow Cytometer (Beckman).
+ Open protocol
+ Expand
2

Comprehensive Flow Cytometry Analysis of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hepatic and adipose immune cells were pre‐incubated with anti‐mouse CD16/32 Fc blocker (BD Pharmingen, USA), followed by staining with the Live/Dead marker anti‐FVD‐APC‐Cy7 (all supplied by eBioscience, San Diego, CA, USA). The fluorochrome‐conjugated antibodies used in this study were anti‐CD45, anti‐CD3, anti‐NK1.1, anti‐CD4, anti‐CD8, anti‐CD44, anti‐CD62L, anti‐CD11b, anti‐F4/80, anti‐Ly6C, anti‐Ly6C, and anti‐Siglec‐F (all supplied by eBioscience, San Diego, CA, USA). Liver mononuclear cells were stimulated with phorbol‐myristate acetate/ionomycin/brefeldin A/monensin for 5 hr in vitro. The cells were fixed and permeabilized using a Fixation/Permeabilization Buffer kit (eBioscience, San Diego, CA, USA). The permeabilized cells were washed with FACS buffer and resuspended in 1% formaldehyde and stained for intracellular cytokines with anti‐IFN‐γ‐PE‐Cy7, anti‐TNF‐α‐APC, and anti‐IL‐17A‐APC fluorochrome‐conjugated antibodies. Stained cells were analyzed using a BD LSRFortessa flow cytometer (BD Biosciences, San Jose, CA, USA), and data were analyzed using FlowJo software (FlowJo, LLC, Ashland, OR, USA).
+ Open protocol
+ Expand
3

Phenotypic Profiling of Liver Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Isolated liver MNCs were resuspended in DPBS containing 0.5% BSA and 0.05% sodium azide. After washing, the cells were pre-incubated with anti-mouse CD16/32 Fc blocker (BD Pharmingen, USA) prior to treatment with antibodies to block non-specific reactions. The cells were stained with fluorescence-conjugated anti-CD45, anti-CD3e, anti-CD4, anti-CD8, anti-CD11b, anti-CD25, anti-CD44, anti-CD69, anti-Ly6C, anti-Ly6G, and anti-F4/80 antibodies (BD Pharmingen, USA). The stained cells were analyzed using a BD™ LSR II Flow Cytometer (BD Pharmingen, USA) and the FlowJo software (Tree Star, Ashland, OR, USA). PE-conjugated anti-IFN-γ and TNF-α antibodies (BD Bioscience, USA) were used for intracellular staining. For intracellular cytokine staining, the cells were re-stimulated with phorbol-myristate acetate/ionomycin for 1 hour in addition to brefeldin A for 5 hours and then the cells were fixed and permeabilized using the BD Cytofix/Cytoperm kit (BD Pharmingen, USA).
+ Open protocol
+ Expand
4

Comprehensive Immune Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were pre-incubated with an anti-mouse CD16/32 Fc blocker (BD Pharmingen, USA), followed by anti-FVD-APC-Cy7 (all supplied by eBioscience, San Diego, CA, USA) to exclude dead cells. After washing with FACS staining buffer, cells were treated with fluorochrome-conjugated monoclonal antibodies for 40 min at 4°C. The monoclonal antibodies used in this study were as follows: anti-CD3-PerCP-Cy5.5, anti-CD3-PE-Cy7, anti-CD4-AF700, anti-CD8-PE, anti-CD8-APC, anti-CD28-APC, anti-CD45RA-FITC, anti-CD45RO-PE-Cy7, anti-CD57-FITC, anti-TCR gamma/delta-FITC, fixable viability dye-APC-Cy7, anti-interferon (IFN)-γ-PE-Cy7, and anti-tumor necrosis factor (TNF)-α-APC (all supplied by eBioscience, San Diego, CA, USA). For intracellular staining, surface-stained cells were stimulated with phorbol-myristate acetate/ionomycin/brefeldin A/monensin for 5 h, and then fixed and permeabilized using a Fixation/Permeabilization Buffer kit (eBioscience, San Diego, CA, USA). The permeabilized cells were washed and resuspended in 1% formaldehyde and stained with anti-IFN-γ-PE-Cy7 and anti-TNF-α-APC. Multicolor flow cytometry was performed using a BD LSRFortessa flow cytometer (BD Biosciences, San Jose, CA, USA), and the data were analyzed by FlowJo V10 software (FlowJo, LLC, Ashland, OR, USA).
+ Open protocol
+ Expand
5

Peptide-Loaded MHC Class I Tetramer Staining

Check if the same lab product or an alternative is used in the 5 most similar protocols
H-2Kb SIY peptide was purchased from MBL medical. SIY peptide loaded H-2K[b]:Ig fusion protein was prepared by incubation of the BD DimerX I H-2K[b]:Ig dimer with 320 molar excess SIY peptide in PBS at 37 ℃ overnight. For immunofluorescent staining, isolated splenocytes were incubated with peptide loaded H-2K[b]:Ig protein on ice for 1 hr after treatment with anti-mouse CD16/32 FcBlocker (BD Pharmingen). After washing, cells were incubated with PE-conjugated A85-1 mAb (BD Pharmingen), and co-stained with α-CD3e (clone 145-2C11, BD Pharmingen) and α-CD8α (clone 53-6.7, BD Pharmingen) antibodies. Samples were acquired using FACS Canto II flow cytometry (BD Biosciences), and analyzed by FlowJo software V10 (TreeStar).
+ Open protocol
+ Expand
6

Characterization of Hepatic Tumor Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hepatic tumorous immune cells were preincubated with anti-mouse CD16/32 Fc blocker (BD Pharmingen, San Diego, CA, USA), followed by staining with the Live/Dead marker FVD-APC-Cy7 (all supplied by eBioscience, San Diego, CA, USA). The fluorochrome-conjugated antibodies used in this study were anti-CD45, anti-CD3, anti-NK1.1, anti-CD4, anti-CD8, anti-CD44, anti-CD62L, anti-CD279, anti-CD11b, anti-F4/80, anti-Ly6C, anti-Ly6C, anti‐Siglec-F, anti-MCL-1, and anti-BCL2 (all supplied by eBioscience). Hepatic tumor immune cells were stimulated with phorbol-myristate acetate/ionomycin/brefeldin A/monensin for 5 hours in vitro. Cells were fixed and permeabilized using the Fixation/Permeabilization Buffer kit (eBioscience), washed with FACS buffer, resuspended in 1% formaldehyde, and stained with anti‐IFN-γ-APC. Stained cells were analyzed using a BD LSRFortessa flow cytometer (BD Biosciences, San Jose, CA, USA) and the data were analyzed using the FlowJo software (FlowJo, LLC, Ashland, OR, USA). The antibodies used are listed in online supplemental table S3.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!